Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918981 · ClinicalTrials.gov registry record · NA
Nutritional Strategies to Augment the Postprandial Muscle Protein Synthetic Response to the Ingestion of a Low Dose of Protein in Middle-aged Women
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02918981: Completed NA study, sponsored by University of Illinois at Urbana-Champaign.
NCT02918981 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02918981, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Using stable isotope methodology, investigators will determine the postabsorptive and postprandial muscle protein synthetic response in 60 female adults (Age 50-79, BMI: \<30 kg/m2) immediately after an acute bout of resistance exercise. Participants will be divided in to 5 groups of twelve women (n=12). Each group will receive a different protein beverage or placebo to consume following the resistance exercise training. Group 1 will consume a beverage consisting of whey protein; group 2 will consume whey protein supplemented with additional leucine; group 3 will consume whey protein supplemented with additional leucine and hydrolyzed whey peptides; group 4 will consume whey protein supplemented with additional leucine and citrulline; group 5 will just consume water. During the testing, blood and muscle samples will be collected.
Primary Outcome
Myofibrillar protein synthesis rates will be assessed during the postabsorptive period for 3 hr and during the 4 hr after the ingestion of the experimental beverages. This will allow us to assess the change from the postabsorptive to the postprandial period
Interventions
- BEHAVIORAL Resistance Exercise
- DIETARY_SUPPLEMENT 14 g Whey protein
- DIETARY_SUPPLEMENT 6.6 g Whey protein + 1.25 g leucine
- DIETARY_SUPPLEMENT 4 g Whey protein + 1.25 g leucine + 2.6 g Whey peptides
- DIETARY_SUPPLEMENT 6.6 g Whey protein + 1.25 g leucine + 0.8 g Citrulline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-10 |
| Est. Completion | 2019-03-06 |
| Phase | NA |
What the finished NCT02918981 record still lists
NCT02918981 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 5 interventions - of which Resistance Exercise is the first listed.
NCT02918981 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02918981 about?
NCT02918981 is a clinical study titled "Nutritional Strategies to Augment the Postprandial Muscle Protein Synthetic Response to the Ingestion of a Low Dose of Protein in Middle-aged Women". Using stable isotope methodology, investigators will determine the postabsorptive and postprandial muscle protein synthetic response in 60 female adults (Age 50-79, BMI: \<30 kg/m2) immediately after an acute bout of resistance exercise. Participants will be divided in to 5 groups of twelve women (n...
What is the current status of trial NCT02918981?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-10. Estimated completion is 2019-03-06.
What interventions are being tested in trial NCT02918981?
The interventions under investigation include: Resistance Exercise (BEHAVIORAL), 14 g Whey protein (DIETARY_SUPPLEMENT), 6.6 g Whey protein + 1.25 g leucine (DIETARY_SUPPLEMENT), 4 g Whey protein + 1.25 g leucine + 2.6 g Whey peptides (DIETARY_SUPPLEMENT), 6.6 g Whey protein + 1.25 g leucine + 0.8 g Citrulline (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02918981?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02918981's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia